--2025/Q1-- / 81.900M--
--2024/Q4-- / 92.500M--
Nov 7, 20242024/Q391.592M / 91.300M--
Aug 8, 20242024/Q294.396M / 107.000M--
May 9, 20242024/Q174.877M / 105.750M--
US Stock MarketDetailed Quotes
IRWD Ironwood Pharmaceuticals
- 3.925
- -0.095-2.36%
Trading Nov 19 10:28 ET
628.11MMarket Cap-392500P/E (TTM)
3.990High3.910Low116.83KVolume3.960Open4.020Pre Close461.30KTurnover0.09%Turnover RatioLossP/E (Static)160.03MShares15.70052wk High-2.02P/B486.52MFloat Cap3.79052wk Low--Dividend TTM123.96MShs Float21.200Historical High--Div YieldTTM1.99%Amplitude3.790Historical Low3.948Avg Price1Lot Size
Ironwood Pharmaceuticals Key Stats
Ironwood Pharmaceuticals Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 91.30M | 91.59M | +292.00K |
| Beat Est. | -19.73% | -19.47% | +0.32% |
| EPS | 0.05 | 0.02 | -0.03 |
| Miss Est. | -50.00% | -77.78% | -55.56% |
Analyst Rating
Nov 9, 2024
Ironwood Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Ironwood Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data